Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

260 та иш

Иш: The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update

  1. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

    Hanny Al‐Samkari, Rebecca S. Karp Leaf, Sunny Dzik +10

    Мақола20203 иқтибос
    ABI

  2. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

    Jonas Schulte-Schrepping, Nico Reusch, Daniela Paclik +96

    Мақола20203 иқтибос
    ABI

  3. A possible pathogenic correlation between neutrophil elastase (NE) enzyme and inflammation in the pathogenesis of coronavirus disease 2019 (COVID-19)

    Sajad Karampoor, Khashayar Hesamizadeh, Faezeh Maleki +11

    Мақола20212 иқтибос
    ABI

  4. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications

    Simona Sivori, Paola Vacca, Genny Del Zotto +3

    Шарҳ мақола20192 иқтибос
    ABI

  5. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

    Zhuo Zhou, Lili Ren, Li Zhang +23

    Мақола20202 иқтибос
    ABI

  6. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

    Rudragouda Channappanavar, Stanley Perlman

    Шарҳ мақола20172 иқтибос
    ABI

  7. Neutrophil emigration in the skin, lungs, and peritoneum: different requirements for CD11/CD18 revealed by CD18-deficient mice.

    J P Mizgerd, H Kubo, G J Kutkoski +4

    Мақола19972 иқтибос
    ABI

  8. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients

    Litao Yang, Hui Peng, Zhu Zhao-ling +6

    Мақола20062 иқтибос
    ABI

  9. Understanding the T cell immune response in SARS coronavirus infection

    Hsueh‐Ling Janice Oh, Samuel Ken‐En Gan, Antonio Bertoletti +1

    Шарҳ мақола20122 иқтибос
    ABI

  10. Type I interferons in infectious disease

    Finlay W. McNab, Katrin D. Mayer-Barber, Alan Sher +2

    Шарҳ мақола20152 иқтибос
    ABI

  11. Heparan Sulfate Proteoglycans Are Required for Cellular Binding of the Hepatitis E Virus ORF2 Capsid Protein and for Viral Infection

    Manjula Kalia, Vivek Chandra, Sheikh Abdul Rahman +2

    Мақола20092 иқтибос
    ABI

  12. The Human Immune System against Staphylococcus epidermidis

    Rasoul Mirzaei, Rokhsareh Mohammadzadeh, Shokri Moghadam Mohammad +2

    Шарҳ мақола20192 иқтибос
    ABI

  13. Functional exhaustion of antiviral lymphocytes in COVID-19 patients

    Meijuan Zheng, Yong Gao, Gang Wang +5

    Бошқа20202 иқтибос
    ABI

  14. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia

    Fan Wang, Jiayan Nie, Haizhou Wang +7

    Мақола20202 иқтибос
    ABI

  15. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

    Evangelos J. Giamarellos‐Bourboulis, Mihai G. Netea, Νikoletta Ρovina +25

    Мақола20202 иқтибос
    ABI

  16. Targeting potential drivers of COVID-19: Neutrophil extracellular traps

    Betsy Barnes, José M. Adrover, Amelia Baxter-Stoltzfus +20

    Мақола20202 иқтибос
    ABI

  17. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

    Bo Diao, Chenhui Wang, Yingjun Tan +12

    Мақола20202 иқтибос
    ABI

  18. A single-cell atlas of the peripheral immune response in patients with severe COVID-19

    Aaron J. Wilk, Arjun Rustagi, Nancy Q. Zhao +12

    Мақола20202 иқтибос
    ABI

  19. Dexamethasone in Hospitalized Patients with Covid-19

    The RECOVERY Collaborative Group

    Мақола20202 иқтибос
    ABI

  20. Tissue damage from neutrophil-induced oxidative stress in COVID-19

    Mireille Laforge, Carole Elbim, Corinne Frère +5

    Шарҳ мақола20202 иқтибос
    ABI

  21. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

    Julian Braun, Lucie Loyal, Marco Frentsch +30

    Мақола20202 иқтибос
    ABI

  22. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

    Naoki Kaneko, Hsiao-Hsuan Kuo, Julie Boucau +48

    Мақола20202 иқтибос
    ABI

  23. A dynamic COVID-19 immune signature includes associations with poor prognosis

    Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio +47

    Мақола20202 иқтибос
    ABI

  24. Targeted therapy strategies against SARS‐CoV‐2 cell entry mechanisms: A systematic review of in vitro and in vivo studies

    Simin Seyedpour, Behzad Khodaei, Amir Hossein Loghman +7

    Шарҳ мақола20202 иқтибос
    ABI

  25. Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils’ but Impaired Monocytes’ and Dendritic Cells’ Responsiveness

    Zuzana Paračková, Irena Zentsová, Markéta Bloomfield +7

    Мақола20202 иқтибос
    ABI